FierceBiotech | Nachrichten

Zeit	Aktuelle Nachrichten
Fr	SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round
Fr	Idera's TLR9-Yervoy combo sees 'impressive' disease control in PD-1-refractory melanoma
Fr	Guardant to develop CDx and TMB liquid biopsy tests for AstraZeneca's targeted cancer therapies
Fr	Eli Lilly and Evidation expand digital biomarker collaboration to data from smartphones and wearables
Fr	Bellicum reports first data on 'controllable' CAR-T
Fr	Chutes & Ladders-Gilead swipes Roche pharma chief for CEO post
Fr	Sensorion's vertigo drug hits tolerability endpoint in phase 2
Fr	Axovant buys more gene therapies, setting it up for a busy 2019
Do	Owkin launches global patient data sharing network for training AIs
Do	CRISPR controls obesity in mice by amplifying rather than editing genes
Do	FDA clears AR safety warning system for minimally invasive surgeries
Do	Could a once-abandoned obesity drug be revived in osteoporosis?
Do	Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
Do	Amag merges with Perosphere, adding NOAC antidote
Do	NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients
Do	Biogen bails on AGTC after ocular gene therapy flunks trial
Do	Biofrontera cleared of wrongdoing in Nasdaq IPO
Do	FDA hails 2018 as bumper year for drug development successes
Do	AstraZeneca links with Cancer Research UK to debut new functional genomics center
Mi	TrialSpark debuts first clinical trial sites as part of deal with Novartis
Mi	Target PharmaSolutions closes out the year with a pair of partnerships
Mi	Parexel and Eli Lilly team up in effort to bolster clinical trial R&D program in China
Mi	Cancer-killing virus plus PD-1 and MEK inhibitors make for a 3-pronged attack on melanoma
Mi	Roche to develop new dMMR pan-cancer test for Merck's Keytruda immunotherapy
Mi	GenSight rebuilds its case for LHON gene therapy, eyeing filing next year

Zeit

Aktuelle Nachrichten

SoftBank returns to back synthetic biology firm Zymergen in a $400M series C round

Idera's TLR9-Yervoy combo sees 'impressive' disease control in PD-1-refractory melanoma

Guardant to develop CDx and TMB liquid biopsy tests for AstraZeneca's targeted cancer therapies

Eli Lilly and Evidation expand digital biomarker collaboration to data from smartphones and wearables

Bellicum reports first data on 'controllable' CAR-T

Chutes & Ladders-Gilead swipes Roche pharma chief for CEO post

Sensorion's vertigo drug hits tolerability endpoint in phase 2

Axovant buys more gene therapies, setting it up for a busy 2019

Owkin launches global patient data sharing network for training AIs

CRISPR controls obesity in mice by amplifying rather than editing genes

FDA clears AR safety warning system for minimally invasive surgeries

Could a once-abandoned obesity drug be revived in osteoporosis?

Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint

Amag merges with Perosphere, adding NOAC antidote

NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients

Biogen bails on AGTC after ocular gene therapy flunks trial

Biofrontera cleared of wrongdoing in Nasdaq IPO

FDA hails 2018 as bumper year for drug development successes

AstraZeneca links with Cancer Research UK to debut new functional genomics center

TrialSpark debuts first clinical trial sites as part of deal with Novartis

Target PharmaSolutions closes out the year with a pair of partnerships

Parexel and Eli Lilly team up in effort to bolster clinical trial R&D program in China

Cancer-killing virus plus PD-1 and MEK inhibitors make for a 3-pronged attack on melanoma

Roche to develop new dMMR pan-cancer test for Merck's Keytruda immunotherapy

GenSight rebuilds its case for LHON gene therapy, eyeing filing next year

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FierceBiotech